THURSDAY, DECEMBER 17, 2020

SESSION 1

12:00

Opening remarks and presentation of Gertrude Elion Distinguished Lecturer Award

Raymond F. Schinazi

Emory University, USA

12:45

Plenary talk: SARS-CoV-2 therapeutic challenges

Ralph Baric

University of North Carolina, USA


13:20

Animal models and vaccine development against SARS-CoV-2

Johan Neyts

University of Leuven, Belgium


Oral Abstract Session

14:00

Broad-spectrum therapeutics against SARS-CoV-2 3CL protease

Ladislau Kovari

Wayne State University, USA


14:20

Peginterferon-lambda for the treatment of COVID-19 in outpatients

Jordan Feld

University of Toronto, Canada


SESSION 2

14:40

Utility of Remdesivir alone and in combination for COVID-19

Andre Kalil

University of Nebraska Medical Center, USA


15:00

SARS-CoV-2 transmission, fitness, and pathogenesis

Vineet Menachery

University of Texas, USA


15:25

Drugs and vaccines for RSV and COVID-19 (non-CME)

Martin Moore

Meissa Vaccines, USA


16:25

Special lecture: The story of baricitinib, and after

Justin Stebbing

Imperial College London, UK


16:45

Concluding remarks

Raymond F. Schinazi

Emory University, USA

 

CME Accreditation:

The Emory University School of Medicine designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits. This accreditation is for both days of the conference (HIV DART: December 10, 2020 and Respi DART: December 17, 2020). Physicians should claim only the credit commensurate with the extent of their participation in the activity. Fees associated with obtaining credits incude $35 USD for both days of the meeting.

The Emory University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Please submit your certification request through this link. Please contact us at info@ihorizonsed.com for additional information.